Cantor Fitzgerald Upgrades RenaissanceRe (NYSE:RNR) to “Overweight”

RenaissanceRe (NYSE:RNRGet Free Report) was upgraded by Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a research note issued to investors on Thursday. The firm presently has a $340.00 target price on the insurance provider’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 10.66% from the company’s current price.

Other research analysts have also issued research reports about the stock. Wall Street Zen raised shares of RenaissanceRe from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays increased their price objective on shares of RenaissanceRe from $310.00 to $341.00 and gave the company an “equal weight” rating in a report on Wednesday. Evercore raised their price objective on shares of RenaissanceRe from $283.00 to $291.00 and gave the company an “in-line” rating in a research note on Wednesday, February 4th. Citigroup upped their target price on shares of RenaissanceRe from $328.00 to $333.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Finally, Keefe, Bruyette & Woods increased their price target on RenaissanceRe from $323.00 to $327.00 and gave the company a “market perform” rating in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, RenaissanceRe currently has a consensus rating of “Hold” and an average target price of $309.57.

Read Our Latest Report on RNR

RenaissanceRe Trading Up 1.5%

Shares of RNR opened at $307.25 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.21. RenaissanceRe has a 12-month low of $222.75 and a 12-month high of $315.88. The firm has a market capitalization of $13.26 billion, a PE ratio of 5.42, a price-to-earnings-growth ratio of 0.70 and a beta of 0.24. The stock’s fifty day simple moving average is $297.37 and its 200-day simple moving average is $275.97.

RenaissanceRe (NYSE:RNRGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.59 by $2.75. The business had revenue of $2.97 billion for the quarter, compared to analysts’ expectations of $1.73 billion. RenaissanceRe had a return on equity of 18.29% and a net margin of 20.88%.The firm’s quarterly revenue was up 29.6% compared to the same quarter last year. During the same quarter last year, the business earned $8.06 earnings per share. As a group, research analysts predict that RenaissanceRe will post 26.04 earnings per share for the current year.

Insider Transactions at RenaissanceRe

In other RenaissanceRe news, EVP Robert Qutub sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $305.75, for a total value of $1,528,750.00. Following the completion of the sale, the executive vice president owned 73,023 shares of the company’s stock, valued at approximately $22,326,782.25. This represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Hedge Funds Weigh In On RenaissanceRe

Several institutional investors and hedge funds have recently made changes to their positions in RNR. Hsbc Holdings PLC increased its position in shares of RenaissanceRe by 3,272.6% in the 4th quarter. Hsbc Holdings PLC now owns 28,195 shares of the insurance provider’s stock valued at $7,968,000 after buying an additional 27,359 shares in the last quarter. Rockefeller Capital Management L.P. lifted its holdings in RenaissanceRe by 64.8% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,989 shares of the insurance provider’s stock worth $559,000 after acquiring an additional 782 shares in the last quarter. World Investment Advisors bought a new position in RenaissanceRe during the fourth quarter worth about $224,000. Corient Private Wealth LLC grew its stake in RenaissanceRe by 36.2% in the fourth quarter. Corient Private Wealth LLC now owns 11,630 shares of the insurance provider’s stock valued at $3,270,000 after acquiring an additional 3,091 shares during the period. Finally, Rehmann Capital Advisory Group grew its stake in RenaissanceRe by 22.5% in the fourth quarter. Rehmann Capital Advisory Group now owns 1,729 shares of the insurance provider’s stock valued at $488,000 after acquiring an additional 318 shares during the period. Institutional investors and hedge funds own 99.97% of the company’s stock.

RenaissanceRe News Roundup

Here are the key news stories impacting RenaissanceRe this week:

  • Positive Sentiment: Keefe, Bruyette & Woods (KBW) forecast strong price appreciation for RNR, reflecting confidence in the company’s outlook and valuation — this kind of bullish analyst commentary tends to lift investor sentiment. KBW Forecast
  • Positive Sentiment: Barclays raised its price target to $341 (now “equal weight”), representing roughly an 11% upside vs. the reference price; a notable upward revision that can drive buying interest. Benzinga
  • Positive Sentiment: Keefe, Bruyette & Woods also lifted its target from $323 to $327 and maintained a “market perform” rating — another incremental analyst upgrade supporting the rally. Benzinga
  • Positive Sentiment: UBS raised its target to $319 (still “neutral”), a modest upside revision that signals analysts are marking up fair value after recent results. Benzinga
  • Positive Sentiment: Zacks included RNR among P&C insurers positioned to benefit from digitalization and favorable pricing dynamics after recent catastrophe activity — a sector tailwind that supports reinsurance pricing and renewals. Zacks Industry Note
  • Neutral Sentiment: Coverage aggregation shows an average broker rating of “Hold,” indicating the market consensus is cautious despite the recent target increases — this tempers expectations for a sustained run-up. Brokerage Consensus
  • Neutral Sentiment: Standalone Zacks commentary and a CNN markets profile provide valuation/earnings context for value investors weighing RNR; these pieces are informational rather than new catalysts. Zacks Buy Piece CNN Profile

About RenaissanceRe

(Get Free Report)

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.

Read More

Analyst Recommendations for RenaissanceRe (NYSE:RNR)

Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.